Tardive Dyskinesia caused by neuroleptic drugs Completed Phase 4 Trials for Olanzapine (DB00334)
Also known as: Neuroleptic-Induced Tardive Dyskinesia / Drug induced subacute dyskinesia / Neuroleptic-induced tardive dyskinesia (disorder)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0093521 (Tardive Dyskinesia caused by neuroleptic drugs) | Completed | 4 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00621998 | Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia | Treatment |